Federal Official Gazette
No updates.
ANS news
ANS holds 54th Technical Meeting of Cosaúde
The meeting will take place on Aug 25. See the schedule
August 25, 2026
9 a.m. – Discussion of proposals for inclusion in the List of Health Procedures and Events (Rol) concerning the following technologies:
SHIFT
TECHNOLOGY
INDICATION FOR USE
9 a.m. to 12:30 p.m.
UAT 209 – 21-gene test for genomic expression profiling of breast tumors
(Preliminary discussion)
Support for therapeutic decision-making for patients with early-stage breast cancer (stages I, II and IIIA), hormone receptor-positive (HR+), human epidermal growth factor receptor type 2-negative (HER2-), with node-negative disease or node-positive disease involving one to three lymph nodes.
UAT 184 – Amendment of DUT 110.39 – Molecular DNA analysis
(Continuation of preliminary discussion)
Diagnosis of patients with intellectual disability of undetermined cause.
2 p.m. to 6 p.m.
UAT 202 – Update of DUT 52 – Digital mammography (internal demand)
(Analysis of contributions from social participation)
Screening, diagnosis and treatment follow-up of breast cancer.
UAT 205 – Implantation of a cardiac contractility modulation device
(Preliminary discussion)
Treatment of patients with symptomatic chronic heart failure (NYHA III–IV), refractory to optimized pharmacological treatment, with ejection fraction between 25% and 45%, QRS complex <130 ms, and with no indication for cardiac resynchronization therapy.
Open public consultations
- CP 175. Subject: criticisms and suggestions regarding the preliminary recommendations against incorporating the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Deadline: Aug 12, 2026 to Aug 31, 2026
Scheduled public hearings
- AP 68. Subject: preliminary recommendation against incorporating the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Date: August 20, 2026, from 9 a.m. to 1 p.m., virtually, via the Microsoft Teams platform.
Open public calls for input
There is no open public call for input.
Open public calls
Discount cards, prepaid cards, or related services. Deadline: From Jun 2, 2026 to Aug 18, 2026.
Other news
‘Our market is complementary to that of health plans,’ says CEO of Dr. Consulta
Source: oglobo.globo.com · read the full article
Gilmar Mendes overturns decision that required coverage of automatic insulin pump
Source: jota.info · read the full article
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.